TAM and SAM Assessment - PharmaACE

Case Study

Home / Case Studies / TAM and SAM Assessment

TAM and SAM Assessment

Objective

Assessment of Total Addressable Market (TAM) and Total Serviceable Addressable Market (SAM) for strategic development of small molecule injectables within the key non-US markets

Approach

Conducted indepth market assessment for key non-US markets like Australia, New Zealand, Japan, China, Western EU, Canada
Identified and monitored key metrics like sales and volume to arrive at TAM and SAM
Shortlisted unique molecules available in key therapy areas such as solid tumors, hematology and immunology, in each market

Outcome

Identified the correct opportunity for the product using appropriate market filters
Estimated the addressable market size for the client product
Identified untapped opportunities for client product in new markets and therapy areas
Mapped mandatory requirements and approval processes in each market set by the various regulatory bodies
Finalized list of products for further clinical development and commercial launch

Client Benefits

Helped gain comprehensive market understanding for the launch of products across all key regions
Helped identify and measure KPIs that reflect the true performance of the product across markets and therapy areas
Narrowed down to a list of products best suited for business expansion as per client’s strategic requirements
Also got inputs for optimal utilization of existing work force and developmental capabilities

Competitive Intelligence